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Summary
It has been demonstrated, in certain autoimmune disease models, that pathogenicT cells express
antigen receptors of limited diversity. It has been suggested that the T cells responsible for the
pathogenesis of type I diabetes mellitus might similarly demonstrate restricted T cell receptor
(TCR) usage . Recently, attempts have been made to identify theVa subset(s) that initiates and/or
perpetuates the andislet response in a mouse model of spontaneous autoimmune diabetes (non-
obese diabetic [NOD] mice) . In studies reported here, we have bred NOD mice to a mouse
strain that congenitally lacks approximately one-halfof the conventionalTCR V/3 alleles. Included
in this deletion are TCR V0 gene products previously implicated as being involved in the
pathogenesis ofNOD disease . By studying second backcross-intercross animals, we were able
to demonstrate that this deletion ofTCR V0 gene segments did not prevent the development
of insulitis or diabetes .
Insulin-dependent diabetes mellitus (IDDM)' results from
the destruction ofthe insulin-producinga cells ofthe pan-
creatic islets of Langerhans . The development of spontaneous
IDDM in animal models, as well as in humans, has been shown
to have an autoimmune pathology that arises through a com-
plex pattern of genetic inheritance (1-6) . One animal model
of spontaneous diabetes, the non-obese diabetic (NOD) mouse,
has demonstrated pathology analogous to thehuman disease,
including islet-associated mononuclear cell infiltration (insu-
litis) and serologically detectable autoantibodies to a number
of /3 cell-specific components (7-10) . Both occur before the
onset of overt hyperglycemia.
A pathogenic role for T lymphocytes in the destruction
of islets has been demonstrated for NOD mice (8-10) and
also implicated forhuman IDDM. There are now numerous
examples, both in normal and pathologic immune responses,
where there is preferential if not exclusive activation of T
cells expressing particular TCR V(3 gene segments (11-13).
Several recent studies have suggested that the inflammation
and destruction of pancreatic islet cells in NOD mice may
be mediated by T cells expressing TCR V(35 or V08 gene
segments (14-16) .
In this report we have used a naturally occurring deletion
in the TCR Vo locus to test directly the requirement for
these particular Va gene segments in the development of
l Abbreviations used in this paper. BC2-Ft, second backcross-intercross ;
IDDM, insulin-dependent diabetes mellitus ; NOD, non-obese diabetic.
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NOD diabetes . Most inbred mouse strains, including NOD,
have the TCR Vab haplotype, encoding -20-25 functional
V0 gene elements . However, several strains, such as SWR,
carry the VO' haplotype, where there has been an extensive
deletion of -10 V0 gene segments, including the V05 and
V08 gene families (17) . We crossed the Va' haplotype from
SWR onto theNOD background, and examined the influence
ofTCR V(3 haplotype on the incidence and severity of insu-
litis and diabetes (hyperglycemia) . Our results demonstrate
that deletion ofabout half the wild-type complement ofTCR
V(3 gene segments, including those previously implicated in
disease pathogenesis (14-16), still allowed the development
of insulitis and diabetes .
Materials and Methods
Mice.
￿
NOD mice used in the breeding analysis were derived
from stock breeders generously provided by Dr. Yoko Mullen,
University ofCalifornia at Los Angeles (Los Angeles, CA) . SWR
mice were purchased from The Jackson Laboratory (Bar Harbor,
ME) and femaleNOD mice (6wk old) used in the adoptive transfer
experiments were purchased from Taconic Farms (German Town,
NY) . All mice were housed in Nalgenemicroisolator cages (Roch-
ester, NY) under specific pathogen-free (SPF) conditions, and al-
lowed food and water ad libitum . Development of diabetes was
screened for by visual inspection of cages for evidence ofpolyuria,
and confirmed by measurement of plasma glucose values.
Antibodies.
￿
mAb directed against mouse T cell markers V08
(mAb F23.1) (18, 19) and V#17a(mAb KJ23) (20, 21), and against
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from mouse ascites on Affi-Gel proteinAcolumns (Bio-Radlabora-
tories, Richmond, CA). Theantibodies were conjugated to FITC
or biotin using standard procedures (23) . Allophycocyanin-labeled
mAbs directed against the Ly-1 pan-T cell marker (24) were the
generous gift ofDr. Alan Stall, Stanford University (Stanford, CA).
Fluorescence Staining. FRCS® analysis of PBL from BC2-F1
mice and control NOD, SWR, and (NOD x SWR)F1 mice was
carved out as previously described (25) . Briefly, Ficoll-purified PBL
were incubated with 25-50 Al titered, labeled antibodies at 4°C
for 20 min. The cells were washed three times in ice coldPBSplus
2% FCS and 0.1% azide . The cells were resuspended in propidium
iodide to label dead cells. Cells were analyzed on a modified dual
laser FAGS 11® system (Becton Dickinson & Co., Mountain View,
CA) equipped with logarithmic amplifiers . A primarily lympho-
cyte population was obtained for analysis by selective gating with
forward and obtuse scatter.
Histology .
￿
Pancreatawere dissectedfrom freshly killed cadaver
mice and prepared for histology by either : (a) quick freezing of
tissue on OCT compound (Miles Inc., Elkhart, IN) over dry ice,
or (b) overnight fixation in neutral buffered formalin and paraffin
embedding. The resultant blocks were sectioned and stained with
hematoxylin and eosin and viewed by light microscopy .
Adoptive Transfer . Splenocytes were transferred from BC2-F 1
mice and controlNOD mice according to a modified protocol of
Wicker et al . (26) . Recipients for adoptive transfer were female
NOD mice, 45-55 d old, that were whole body irradiated (775
rad) (250 kv, 16 milliamp ; Philips, Hamburg, Germany) within 4h
of intravenous injection of donor splenocytes. Pancreata from spleno-
cyte donor mice (NOD, V/32/a, or VO'/b BC2-F1) were screened
for the presence of insulitis by hematoxylin and eosin staining of
1k Backcross 1 ? breeder had IDDM
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frozen pancreas sections before splenocyte preparation . Spleens from
suitable donors were teased apart into single cell suspensions and
washed twice in RPM1 (Gibco Laboratories, Grand Island, NY)
enriched with 2% FCS. 2 x 10 1 cells in 0.5 ml were injected into
the tail vein of recipient NOD mice. Recipient mice were moni-
tored for the presence of hyperglycemia by plasma glucose mea-
surement (Beckman glucose analyze; Beckman Instruments, Palo
Alto, CA) beginning 14 d after splenocyte transfer. Diabetes was
defined by plasma glucose values >500 mg/dl .
Results
Breeding andPhenotyping of V,8°% Intercross Mice.
￿
To ob-
tain progeny homozygous for theTCR V(3 deletion haplo-
type (Voa) on the background of diabetogenic genes from
the NOD strain, mice were bred according to the scheme
shown in Fig . 1 . NOD mice (H-2°od, Vob) were crossed
with SWR mice (H-2q, V0a), and the Fl progeny were
crossed back to NOD. We previously reported that, in the
first backcross generation, diseasewas observed at similar fre-
quencies in both V0a/b and Vob/b mice homozygous for
H-2°od (25) . To select for transmission of the various reces-
sive alleles required for susceptibility to diabetes (5, 6), dia-
betic H-2°oa/n.1 females typed as V(3a /b were selected from
this first backcross generation and crossed to NOD males .
Vaa/b progeny derived from one diabetic female from this
second backcross (BC2) were intercrossed, and theresultant
BC2-Ft generation was typed by cytofluorometric analysis
using twoTCRVO-specificmAbs, F23.1 andKJ23 . The an-
T Cell Receptor V0 Gene Requirements for Non-obese Diabetes
Figure 1 .
￿
Breeding protocol to de-
rive mice homozygous for theTCR Via
deletion (V02/a) on the NOD back-
ground . SWR mice (H-2q, Vaa) were
bred with NOD mice (H-2n-d, VOb),
and the F1 progeny were backcrossed
to NOD. From this first backcross
generation, a diabetic femalemouse that
carried the H-2nd haplotype and was
TCR Vsa/b was backcrossed to an
NODmale to derive a second backcross
generation that was H-2°od/nod, carried
the required genes fordiabetes, and had
TCR VO-/b progeny. The second back-
cross mice that carried the Vga/bTCR
haplotype were intercrossed to derive
a second backcross-intercross genera-
tion .ThePBL of these progeny (BC2-
F1) were screened by cytofluorometric
analysis ; TCR haplotypes segregated in
the expected distribution of 1:2 :1 for
the V0a/a/Vaa/b/V0b/b haplotypes,
respectively.tibody F23.1 recognizes all three members of the V08 gene
family (18, 19) ; these gene segments areamong those deleted
in the V0a haplotype (17) . KJ23 is specific for the V017a
gene product, encoded by the VRa haplotype (20, 21) ; the
V)3b haplotype has no functional V017 gene (21) . The BC2-
Fl generation could thus be typed as Vaa/a (F23.1 - , KJ23+),
VRa/b (F23.1+, KJ23+), or Vab/b (F23.1+, KJ23 -) (Fig . 2) .
Effect ofV,#Haplotype on Insulitis.
￿
To determine the effect
that TCR Va haplotype might have on the inductive phase
of islet destruction, pancreata from BC2-Ft mice were
studied by histologic analysis for evidence of the lympho-
cytic infiltration (insulitis) into the islets . In our inbredNOD
colony, insulitis begins at -30-40 d of age with the accumu-
lation of lymphocytes in the vasculature and ducts near the
islets. Progressive inflammation ofthe islet parenchyma leads
ultimately to islet (3 cell destruction . Loss of insulin secre-
tory function and clinical diabetes occur at -200 d . In the
BC2-Ft mice, severe insulitis was apparent in pancreata from
mice expressing all three TCR phenotypes by 100 d of age .
The morphology ofthese lesions was indistinguishable from
those seen in inbredNOD mice. 8 of 10 Voa/a BC2-Ft mice
had widespread insulitic lesions, and the majority of these
mice demonstrated severe intra-islet inflammation (Fig. 3) .
Most of the pancreata examined from Voa/b heterozygotes
(9/11) and Vob/b homozygotes (4/5) also had extensive in-
sulitis. Thus, T cells bearing receptors derived from the dele-
tion haplotype Vaa, lacking both Va5 and V08 families,
could initiate the early stages ofNOD disease.
Effect ofV#Haplotypeon Diabetes.
￿
Progression to clinical
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Figure 2 . Determination of TCR
haplotype for Vaaia, V(3blb homozy-
gotes, and V#-/b heterozygotes in
(NOD x SWR) BC2-F1 mice by
cytofluorometric analysis . T lympho-
cytes from peripheral blood of BC2-F1
mice were double labeled using an
allophycocyanin-conjugated Ly-1 mAb
in conjunction with either of two flu-
orescein-conjugated V(3specific mAbs,
F23 .1 or KJ23 . mAb F23 .1 binds to all
three members of the V08 family that
are deleted in the V/3° haplotype and
therefore specifically labels Vlb cells;
thus, the antibody labels NOD (Vob/b)
and (NOD x SWR)Ft (Vaa/b) but
not SWR (Vga/a) T cells . mAb KJ23
binds to the V#17a that is functionally
expressed by Vaa haplotype mice, but
not Vab ; thus, the antibody labels
SWR and (NOD x SWR)F 1 but
not NODT cells. Staining with F23 .1
(top) is shown as a 5% probability con-
tour plot, whereas staining with KJ23
(bottom) is expressed as a 50% loga-
rithmic contour plot .
diabetes (hyperglycemia) in NOD mice is always preceded
by insulitis . However, the mere presence of insulitis does not
necessarily lead to overt disease (3) . At least one non-MHC
gene is thought to initiate inflammation, while the later patho-
genic steps are controlled by other diabetogenic genes, in-
cluding the NOD MHC (27) . We therefore followed a co-
hort of BC2-F t mice for >200 d for evidence of overt
diabetes. The criteria for diabetes was plasma glucose values
in excess of 500 mg/dl (nl = <150) . Diabetes incidence in
our inbredNOD colony is60-70% in females, and 10-20%
in males by 200 d . As shown in Table 1, mice heterozygous
or homozygous for the NOD-derived Vob locus had a dis-
ease incidence of -30% by 210 d of age. Disease occurred
in both male and females . In the Vaa/a mice, the disease in-
cidence was reduced compared to Vob/a or Vob/b litter
mates ; however, fulminant disease still occurred in 2 of 16
(12.5%) Voa/a mice. The incidence was not statistically
different among the groups. The finding that the Voa/a mice
could develop overt disease demonstrated that those TCR
V/3 gene segments deleted in the Vaa haplotype were not
required for the development of diabetes .
V,#° Splenocytes Transfer Disease. To establish whether
lymphocytes from the BC2-Ft mice that had not developed
IDDM could mediate islet destruction in an environment con-
taining all the background genes from NOD, we adoptively
transferred lymphocytes from nondiabetic V)32/2 and Voa/b
BC2-Ft mice into youngNOD mice (26) . Normoglycemic
BC2-F t mice, >200 d old (all with documented insulitis)
were used as lymphocyte donors . Lethally irradiated 7-wk-Figure 3 .
￿
Inflamed pancreatic islet from a deletion haplotype (Va'/')mouse . Arepresentative section from the pancreas of a >100-d-old VS-/- BC2-
F, mouse showing massive accumulation and invasion of lymphocytes into the islet parenchyma. The section is visualized by light microscopy at x400 .
old female NOD mice were used as recipients. Without ma-
nipulation, theseNOD recipients would not be expected to
develop hyperglycemia for at least 100 d . The data presented
in Table 2 demonstrate that spleen cells from either the Va
deletion (Vo'h) or heterozygous (Vaa/b) donors induced ac-
celerated disease in recipients since overt hyperglycemia could
be seen within 24 d after transfer in recipient mice . The inci-
dence was as high or higher than that seen using cells trans-
ferred from inbred NOD mice.
Table 1 .
￿
Effect of TCR Va Haplotype on IDDM Incidence in
BC2-F, Mice
Va haplotype
￿
IDDM incidence
￿
Mean day of onset
Vo./.
Vaa/b
`jab/b
2/16 (12.5%)
￿
160 ± 30
10/35 (28.6%)
￿
170 ± 30
5/15 (33.3%)
￿
165 ± 11
BC2-Ft mice were followed by visual inspection of their cages for evi-
dence of polyuria and periodically bled for blood glucose determination.
The incidence andmean day ofonset ofovert hyperglycemia are present-
ed . IDDM was defined as a blood glucose value in excess of 500mg/dl
(nl - C150 mg/dl) .
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Discussion
The results reported here demonstrate thatTCRVS gene
families 5, 8, 9, 11, 12, and 13, deleted in the Va' haplo-
type, are not required for development of insulitis or dia-
betes in this model of spontaneous diabetes . These findings
differ significantly from previous reports in which theT cells
Table 2.
￿
Disease Acceleration by Adoptive Transfer of
BC2-F, Splenocytes
NOD (Vab/b)
Vaa/b
VRa/a
T Cell Receptor Va Gene Requirements for Non-obese Diabetes
TCR haplotype
￿
Recipient with IDDM
0/3, 0/3, 3/4, 4/4
0/2, 0/4, 2/4, 3/3, 3/3
0/4, 3/3, 4/4, 4/4
Splenocytes from individual nondiabetic BC2-F, mice with the Va de-
letion (V01/') were adoptively transferred into lethally irradiated (775
rad) young femaleNOD recipients (three to four recipients/donor spleen) .
Each fraction represents the number ofdiabetic recipients/transferred mice
per donor spleen . Splenocytes from nondiabetic BC2-Ft TCR heter-
ozygotes (V(3°/b) and NOD mice were used as controls . Data are ex-
pressed as number of recipient mice with overt hyperglycemia 18-24 d
after splenocyte transfer .expressing receptors of the Va5 (14) and VS8 (15, 16) fami-
lies were implicated as the major pathogenic T cell subsets
in NOD diabetes. Those studies (14-16) utilized methods
of T cell cloning or anti-V#-directed mAb therapy to address
this issue. Here, by formal genetic analysis, we have demon-
strated that diabetes can develop in the absence of T cells
expressing gene segments from these families.
Our results may be interpreted in several ways. First, the
antiislet T cell response may be polyclonal at its inception,
therefore, the "inductive" pathologic T cells may not dem-
onstrate predominant TCR VO gene usage. Such a polyclonal
"inductive" response would contrast that seen in another mu-
rine autoimmunedisorder, experimental allergicencephalomye-
litis, where T cells of a single autoantigen specificity and con-
served TCR V(3 usage have been shown to induce and
perpetuate the autoimmune pathology (13, 28, 29). Second,
initiation of the diabetogenic events in NOD mice may de-
pend upon T cells utilizing a particular Vii gene segment(s)
that is encoded by the portion of chromosome 6 preserved
in Vf' mice, and thus shared by both V#' and Vab haplo-
types. A third possibility is that in NOD mice, disease is
indeed triggered by T cellsusinga TCR V/3 gene segment(s)
that maps within the region deleted in the Va' haplotype
(such as V)35 or V#8), but NOD V/3' mice (BC2-Ft), in
the absence of this gene segment, might compensate for the
deletion(s) by shifting Va usage without affecting recogni-
tion of the autoantigen. We and others have recently shown
that while T cells expressing particular TCR V,3 gene seg-
ments may predominate in response to a known antigen, ex-
cellent responses can be made by T cells expressing alterna-
tive TCR Vl genes if T cells expressing the preferred genes
are unavailable (30-34). Although we currently cannot choose
amongthese three possibilities, the data presented in this manu-
script demonstrate that the TCR Va genes deleted in the
V(3' haplotype are not required for the induction of IDDM
in this model.
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